Adicet Bio Inc (NASDAQ:ACET)
| 8.57 Delayed Data As of Oct 21 |  +0.14 / +1.66%Today’s Change | 6.25 Today|||52-Week Range 17.80 | -39.00% Year-to-Date |
Latest ACET News | Press Releases
No recent news for Adicet Bio Inc.
Today’s Trading
| Previous close | 8.43 |
| Today’s open | 8.74 |
| Day’s range | 8.52 - 8.75 |
| Volume | 1,888 |
| Average volume (3 months) | 139,334 |
| Market cap | $256.0M |
Data as of 3:59pm ET, 10/21/2021
Growth & Valuation
| Earnings growth (last year) | +70.32% |
| Earnings growth (this year) | +60.85% |
| Earnings growth (next 5 years) | +11.78% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 5.74 |
| Price/Book | 1.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYRSSyros Pharmaceutical... | -0.03 | -0.69% |
| XOMAXOMA Corp | -0.28 | -1.17% |
| DRIODarioHealth Corp | -0.35 | -2.12% |
| SRRASierra Oncology Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 10/21/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $17.9M |
| Annual profit (last year) | -$36.7M |
| Net profit margin | -204.87% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
